cGMP Manufacturing Base

 

 

 

Our cGMP commercial-scale manufacturing base covers an area of 1,200,000 square feet. It is built to meet the demands of commercialization of peptides and generic APIs for regulated US & EU market.

We began the construction in March, 2009. By the end of 2010, we finished the first phase of construction and installed equipment. In 2012-2013, we will submit 4 DMFs and prepare for FDA inspections as well.

Sinopep will definitely be your reliable partner by providing high quality, cost-saving APIs for your new drug development.

 

 

 

 

 

 

 

 

  • Peptides
  • Generic APIs
  • Custom Peptide Synthesis